New Directions in the Management of Recurrent Ovarian Cancer

In this interactive case-based activity, Mihaela Cristea, MD, City of Hope, will discuss emerging data on PARP inhibitors in the management of recurrent ovarian cancer and case studies that provide a framework for personalized care plans.

Website:

mailto:bamathews@ucdavis.edu